{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:58:20Z","timestamp":1787021900466,"version":"build-2736575974"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0076241","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T23:44:06Z","timestamp":1380584646000},"page":"e76241","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":87,"title":["Familial Occurrence of Systemic Mast Cell Activation Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Gerhard J.","family":"Molderings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Haenisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Bogdanow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Fimmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus M.","family":"N\u00f6then","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"GJ Molderings","year":"2011","journal-title":"J Hematol Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"P Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2012.03627.x","article-title":"Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics","volume":"137","author":"B Haenisch","year":"2012","journal-title":"Immunology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"P Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: Proposed diagnostic criteria","volume":"126","author":"C Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular charac\u00adteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"I Alvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations","volume":"128","author":"MJ Hamilton","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"KH Lim","year":"2009","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.2310\/6650.2005.00006.266","article-title":"Familial cases of mast cell diseases [abstract]","volume":"53","author":"KD Burks","year":"2005","journal-title":"J Invest Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A novel K5091 mutation of KIT identified in familial mastocytosis - in vitro and in vivo responsiveness to imatinib therapy","volume":"30","author":"LY Zhang","year":"2006","journal-title":"Leuk Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaci.2012.04.013","article-title":"Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations","volume":"130","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/jid.2012.394","article-title":"A c-kit mutation in exon 18 in familial mastocytosis","volume":"133","author":"S W\u00f6hrl","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaci.2012.11.040","article-title":"Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis","volume":"131","author":"R Zanotti","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"ref14","first-page":"2095","article-title":"Systemic mast cell disease with gastrointestinal symptoms - a diagnostic questionnaire","volume":"131","author":"GJ Molderings","year":"2006","journal-title":"Dtsch Med Wochenschr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","article-title":"New aspects of liver abnormalities as part of the systemic mast cell activation syndrome","volume":"29","author":"K Alfter","year":"2009","journal-title":"Liver Int"},{"key":"ref16","first-page":"417","article-title":"Allergy","volume":"68","author":"definition Valent P. Mast cell activation syndromes :","year":"2013"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","article-title":"Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder","volume":"42","author":"GJ Molderings","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/205873920601900102","article-title":"Fibromyalgia - new concepts of pathogenesis and treatment","volume":"19","author":"HJ Lucas","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-010-1474-7","article-title":"Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients","volume":"29","author":"I Blanco","year":"2010","journal-title":"Clin Rheumatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1245707","article-title":"Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome","volume":"49","author":"T Frieling","year":"2011","journal-title":"Z Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1160\/TH11-05-0351","article-title":"Bleeding diathesis in patients with mast cell activation disease","volume":"106","author":"H Seidel","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00251-010-0474-8","article-title":"Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects","volume":"62","author":"GJ Molderings","year":"2010","journal-title":"Immunogenetics"},{"key":"ref23","first-page":"2528","article-title":"Genetic evaluation of familial mastocytosis [abstract]","volume":"129","author":"AC Bursztejn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"BJ Longley Jr","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"C Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes","volume":"125","author":"C Teodosio","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/leu.2009.37","article-title":"Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates","volume":"23","author":"A Tefferi","year":"2009","journal-title":"Leukemia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/leu.2011.354","article-title":"Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor \u03b2 chain and KIT V654A","volume":"26","author":"MS Spector","year":"2012","journal-title":"Leukemia"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1182\/blood-2011-12-397588","article-title":"In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells","volume":"120","author":"E Soucie","year":"2012","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e43090","DOI":"10.1371\/journal.pone.0043090","article-title":"Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis","volume":"7","author":"F Traina","year":"2012","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2012.064048","article-title":"Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia","volume":"98","author":"SA Kar","year":"2013","journal-title":"Haematologica"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0076241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:28:42Z","timestamp":1588966122000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0076241"}},"subtitle":[],"editor":[{"given":"Graham R.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,30]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0076241","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,30]]}}}